HK1040078B - 3-(2,4-二氯苄基)-2-甲基-n-(戊璜酰基)-3h-苯並咪唑-5-羧酰胺的晶形 - Google Patents
3-(2,4-二氯苄基)-2-甲基-n-(戊璜酰基)-3h-苯並咪唑-5-羧酰胺的晶形Info
- Publication number
- HK1040078B HK1040078B HK02101470.5A HK02101470A HK1040078B HK 1040078 B HK1040078 B HK 1040078B HK 02101470 A HK02101470 A HK 02101470A HK 1040078 B HK1040078 B HK 1040078B
- Authority
- HK
- Hong Kong
- Prior art keywords
- pentylsulfonyl
- dichlorobenzyl
- benzimidazole
- carboxamide
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/10—Radicals substituted by halogen atoms or nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Reproductive Health (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP32402698 | 1998-11-13 | ||
PCT/JP1999/006296 WO2000029383A1 (fr) | 1998-11-13 | 1999-11-11 | Formes cristallines du 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3h-benzimidazole-5-carboxamide |
Publications (2)
Publication Number | Publication Date |
---|---|
HK1040078A1 HK1040078A1 (en) | 2002-05-24 |
HK1040078B true HK1040078B (zh) | 2004-07-09 |
Family
ID=18161331
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK02101470.5A HK1040078B (zh) | 1998-11-13 | 2002-02-26 | 3-(2,4-二氯苄基)-2-甲基-n-(戊璜酰基)-3h-苯並咪唑-5-羧酰胺的晶形 |
Country Status (11)
Country | Link |
---|---|
US (1) | US6703410B1 (zh) |
EP (2) | EP1132087A4 (zh) |
KR (1) | KR20010080444A (zh) |
CN (1) | CN1136196C (zh) |
AU (1) | AU764594B2 (zh) |
BR (1) | BR9915315A (zh) |
CA (1) | CA2350520A1 (zh) |
HK (1) | HK1040078B (zh) |
HU (1) | HUP0104029A3 (zh) |
RU (1) | RU2228931C2 (zh) |
WO (2) | WO2000028991A1 (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1132087A4 (en) | 1998-11-13 | 2002-06-26 | Fujisawa Pharmaceutical Co | MEDICINE AGAINST POLYCYSTIC OVARY SYNDROME |
WO2000039099A1 (fr) | 1998-12-24 | 2000-07-06 | Fujisawa Pharmaceutical Co., Ltd. | Derives de benzimidazole |
CA2441798C (en) * | 2001-03-27 | 2009-10-20 | Sumitomo Pharmaceuticals Company, Limited | Crystalline isoxazole derivative and medical preparation thereof |
BR0307595A (pt) * | 2002-02-07 | 2005-02-01 | Pfizer | Uso de inibidores de pde5 tal como sildenafil no tratamento de sìndrome de ovário policìstico |
EP1581247A4 (en) * | 2002-12-11 | 2007-09-12 | Amylin Pharmaceuticals Inc | METHODS AND COMPOSITIONS FOR TREATING STEIN-LEVENTHAL SYNDROME |
US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
US20080194860A1 (en) * | 2006-10-10 | 2008-08-14 | Transform Pharmaceuticals, Inc. | Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate |
MX2012001240A (es) * | 2009-07-30 | 2012-06-12 | Aestus Therapeutics Inc | Metodo para el tratamiento de dolor neuropatico con agonistas del derivado de bencimidazol de ppargamma. |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EE04310B1 (et) | 1995-04-21 | 2004-06-15 | Neurosearch A/S | Bensimidasooli ühendid, neid ühendeid sisaldavad farmatseutilised kompositsioonid ja nende kasutamine |
IL118474A (en) * | 1995-06-01 | 2001-08-08 | Sankyo Co | Benzimideol derivatives and pharmaceutical preparations containing them |
JPH09165371A (ja) * | 1995-10-09 | 1997-06-24 | Sankyo Co Ltd | 複素環化合物を含有する医薬 |
EA002357B1 (ru) * | 1995-12-28 | 2002-04-25 | Фудзисава Фармасьютикал Ко., Лтд. | Производные бензимидазола |
AU4400597A (en) * | 1996-10-08 | 1998-05-05 | Fujisawa Pharmaceutical Co., Ltd. | Indole derivatives |
JP3268242B2 (ja) * | 1996-11-14 | 2002-03-25 | 三共株式会社 | 縮合複素環化合物を含有する医薬 |
TW453999B (en) * | 1997-06-27 | 2001-09-11 | Fujisawa Pharmaceutical Co | Benzimidazole derivatives |
CN1150167C (zh) * | 1998-04-06 | 2004-05-19 | 藤泽药品工业株式会社 | 吲哚衍生物 |
EP1132087A4 (en) * | 1998-11-13 | 2002-06-26 | Fujisawa Pharmaceutical Co | MEDICINE AGAINST POLYCYSTIC OVARY SYNDROME |
-
1999
- 1999-11-10 EP EP99972100A patent/EP1132087A4/en not_active Withdrawn
- 1999-11-10 WO PCT/JP1999/006267 patent/WO2000028991A1/ja not_active Application Discontinuation
- 1999-11-11 AU AU11783/00A patent/AU764594B2/en not_active Ceased
- 1999-11-11 HU HU0104029A patent/HUP0104029A3/hu unknown
- 1999-11-11 CN CNB998143251A patent/CN1136196C/zh not_active Expired - Fee Related
- 1999-11-11 EP EP99972205A patent/EP1138674A4/en not_active Withdrawn
- 1999-11-11 US US09/831,082 patent/US6703410B1/en not_active Expired - Fee Related
- 1999-11-11 KR KR1020017006041A patent/KR20010080444A/ko not_active Application Discontinuation
- 1999-11-11 CA CA002350520A patent/CA2350520A1/en not_active Abandoned
- 1999-11-11 BR BR9915315-7A patent/BR9915315A/pt not_active IP Right Cessation
- 1999-11-11 WO PCT/JP1999/006296 patent/WO2000029383A1/ja not_active Application Discontinuation
- 1999-11-11 RU RU2001116105/04A patent/RU2228931C2/ru not_active IP Right Cessation
-
2002
- 2002-02-26 HK HK02101470.5A patent/HK1040078B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1132087A4 (en) | 2002-06-26 |
EP1138674A4 (en) | 2002-08-21 |
EP1132087A1 (en) | 2001-09-12 |
WO2000029383A1 (fr) | 2000-05-25 |
EP1138674A1 (en) | 2001-10-04 |
CN1330641A (zh) | 2002-01-09 |
US6703410B1 (en) | 2004-03-09 |
HUP0104029A3 (en) | 2002-07-29 |
HUP0104029A2 (hu) | 2002-05-29 |
BR9915315A (pt) | 2001-08-07 |
RU2228931C2 (ru) | 2004-05-20 |
AU1178300A (en) | 2000-06-05 |
CA2350520A1 (en) | 2000-05-25 |
KR20010080444A (ko) | 2001-08-22 |
AU764594B2 (en) | 2003-08-21 |
HK1040078A1 (en) | 2002-05-24 |
CN1136196C (zh) | 2004-01-28 |
WO2000028991A1 (fr) | 2000-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL380733A1 (pl) | Pochodne 3, 3-difenylopropyloamin, sposoby ich wytwarzania, ich zastosowanie medyczne oraz kompozycja farmaceutyczna | |
AU4675499A (en) | Novel therapeutic agents that modulate neurokinin receptors | |
PL332212A1 (en) | Heteroaroyl derivatives of herbicidal properties | |
EP0719765A3 (en) | Phenylbenzimidazole derivatives | |
EP1066279A4 (en) | ANOREECTIC IMIDAZOLONE COMPOUNDS: II. phenyl derivatives | |
GB0024932D0 (en) | Use of dexmedetomidine for icu sedation | |
AU4425399A (en) | Novel therapeutic agents that modulate 5-ht receptors | |
AU1969800A (en) | Combination of active agents | |
HK1040078A1 (en) | Crystal forms of 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3h-benzimidazole-5-carboxamide | |
PL342060A1 (en) | Derivatives of 1,3,4-oxadiaxolone | |
PL322721A1 (en) | Derivatives of benzimidazole | |
PL344994A1 (en) | Derivatives of 3-(2-oxo-[1,3']bipyrrolidinyl-3-ylidenemethyl)-cephems | |
HUP9701364A3 (en) | Procedure for making (r) and (s) isomers of alfa-metil-2-[3-(trifluor-metil)-fenil]-etil-amin and the isomers and salts | |
AU3476599A (en) | Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression (5-ht1 receptor antagonists) | |
AU8874198A (en) | Antisense treatment of pulmonary hypertension | |
HUP0104698A3 (en) | Use of riluzole for treating acoustic traumas | |
PL343629A1 (en) | Improved process for the manufacture of n-(1-cyanoalkyl)-2-phenoxypropionamide derivatives | |
SG82014A1 (en) | The use of aryl-cyclohexylamine derivatives against cns disorders | |
AU6196599A (en) | Use of substituted 5-hydroxypyrazoles, novel 5-hydroxypyrazoles, methods for theproduction thereof and agents containing the same | |
GB2347301B (en) | Fret face 1 | |
HUP9900123A3 (en) | 1-isothiazolidinone derivatives of azetidine-2-one, processes for the preparation thereof and use thereof | |
AU1251399A (en) | N-alkylation of 5-amino-2,4,6-triiodo-isophthalamides | |
ZA965678B (en) | Epimers of (22rs)-n-(1,1,1-trifluoro-2-phenylprop-2-yl)-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide | |
GB2352450B (en) | Method for producing of 2,3-dimethylbutene-1 and 2,3-dimethylbutene-2 | |
EP1143998A4 (en) | TREATMENT OF HYPERTENSION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20071111 |